Abstract
NOC, NOC! Who's there? We have expanded the body of structure-activity relationships (SAR) regarding the 3-isoxazolecarboxylic acid ethyl esters by the design and synthesis of 5-aryl- and 5-[(N-aryl)amino]methyl analogues. Compounds were active against Mycobacterium tuberculosis (Mtb) at sub-micromolar concentrations and, for selected compounds, no toxicity was observed on Vero cells.
Original language | English (US) |
---|---|
Pages (from-to) | 1667-1672 |
Number of pages | 6 |
Journal | ChemMedChem |
Volume | 5 |
Issue number | 10 |
DOIs | |
State | Published - Oct 4 2010 |
Keywords
- Drug design
- Drug discovery
- Isoxazole derivatives
- Tuberculosis
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Pharmacology
- Drug Discovery
- Pharmacology, Toxicology and Pharmaceutics(all)
- Organic Chemistry